Fundamental Technological Developments Required for Increased Availability of Tissue Engineering

Since the initial excitement surrounding successful clinical studies of skin tissue engineering more than 20 years ago (Gallico et al., 1984), steady progress has been made in enhancing the capabilities of tissue engineering and regenerative medicine. Tissue engineering generally depends upon the use of cultured cells. Since living cells do not fall into any of the existing medical product categories, this has created a great challenge for both regulatory agencies and commercial entities. Although various treatment strategies have been developed, the fundamental technologies and infrastructure to support their widespread adoption are still limited. In this chapter, attention was focused on fundamental technology development. Three major areas, i.e., introduction of serum-free culture media, development of cell storage technologies and methodological development for quality assurance of the products, are discussed with special reference to future development of tissue engineering.

[1]  G. Brook,et al.  Expansion of human bone marrow-derived mesenchymal stromal cells: serum-reduced medium is better than conventional medium. , 2010, Cytotherapy.

[2]  J. Gimble,et al.  Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. , 2010, Stem cells and development.

[3]  Péter Horváth,et al.  Enhanced CellClassifier: a multi-class classification tool for microscopy images , 2010, BMC Bioinformatics.

[4]  Joel S Greenberger,et al.  Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblasts , 2008, Aging cell.

[5]  Masahiro Kino-Oka,et al.  Characterization of spatial growth and distribution of chondrocyte cells embedded in collagen gels through a stereoscopic cell imaging system , 2008, Biotechnology and bioengineering.

[6]  Bernd Fischer,et al.  CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging , 2010, Nature Methods.

[7]  M. Toner,et al.  Long-term storage of tissues by cryopreservation: critical issues. , 1996, Biomaterials.

[8]  M. Vemuri,et al.  Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. , 2009, Cytotherapy.

[9]  L. Niklason,et al.  Feasibility of vitrification as a storage method for tissue-engineered blood vessels. , 2006, Tissue engineering.

[10]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[11]  J. Chang,et al.  Ongoing development of image cytometers. , 2010, Bioanalysis.

[12]  C. Compton,et al.  Permanent Coverage of Large Burn Wounds with Autologous Cultured Human Epithelium , 1984 .

[13]  Hajime Ohgushi,et al.  Comparison of Osteogenic Ability of Rat Mesenchymal Stem Cells from Bone Marrow, Periosteum, and Adipose Tissue , 2008, Calcified Tissue International.

[14]  N. Ishiguro,et al.  Osteogenic potential of rat mesenchymal stem cells after several passages. , 2004, Biochemical and biophysical research communications.

[15]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Mutsumi Takagi,et al.  Noninvasive quality estimation of adherent mammalian cells for transplantation , 2010 .

[17]  Michael P. Snyder,et al.  Defined culture conditions of human embryonic stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Robey,et al.  EFFECT OF SERUM ON HUMAN BONE MARROW STROMAL CELLS: EX VIVO EXPANSION AND IN VIVO BONE FORMATION , 2000, Transplantation.

[19]  Yukio Nakamura,et al.  Bio-resource of human and animal-derived cell materials. , 2010, Experimental animals.

[20]  R. Nerem,et al.  Enhanced tissue strength in cryopreserved, collagen-based blood vessel constructs. , 2005, Transplantation proceedings.

[21]  S. Perez,et al.  Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell Research , 2006, Stem cells.

[22]  Y. Ishii,et al.  Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. , 2009, Biochemical and biophysical research communications.

[23]  B. Liu,et al.  Vitrification Solutions for the Cryopreservation of Tissue-Engineered Bone , 2004 .

[24]  B. Meiser,et al.  Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. , 2010, Journal of immunological methods.

[25]  Joseph J Pancrazio,et al.  Enabling tools for tissue engineering. , 2007, Biosensors & bioelectronics.

[26]  L. Rosenberg,et al.  Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. , 2010, Cytotherapy.

[27]  P. Schiller,et al.  Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  A. Zander,et al.  Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. , 2004, Experimental hematology.

[29]  Y. Kato,et al.  [Effectivity of the novel serum-free medium STK2 for proliferating human mesenchymal stem cells]. , 2009, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[30]  C. Laurencin,et al.  Cryopreservation of tissue engineered constructs for bone , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.